Eduardo Varejão Díaz Placencia

Eduardo Varejão Díaz Placencia

Auto-generated profile, based on publicly available information

Eduardo Varejão Díaz Placencia

Hospital Israelita Albert Einstein: Sociedade Beneficente Israelita Brasileira Albert Einstein, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2025 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
LPLaura Palmieri
Laura Palmieri
Helena MalvezziHelena Malvezzi
Helena Malvezzi
BABruna Cestari de Azevedo
Bruna Cestari de Azevedo
EPEduardo Varejão Díaz Placencia
Eduardo Varejão Díaz Placencia
EEliane Antonioli
Eliane Antonioli
SPSérgio Podgaec
Sérgio Podgaec
Highlights ■ MMP-1, MMP-2, and MMP-3 are upregulated in endometriotic lesions. ■ The study findings suggest a senescence-associted secretory phenotype in endometriosis. ■ The study findings support targeting senescence pathways in endometriosis. ABSTRACT Objective: To investigate the roles of cellular senescence and dysfunctional extracellular matrix metalloproteinases (MMPs) in perpetuating chronic inflammation and facilitating the establishment of endometriotic lesions. By analyzing the MMP activity in the endometrial tissue and peritoneal fluid, we aimed to obtain novel insights into the molecular mechanisms

19 January 2026 in Atherosclerosis Plus
Verified
Journal Article
Open access
EPEduardo Varejão Díaz Placencia
Eduardo Varejão Díaz Placencia
EFElisângela Farias-Silva
Elisângela Farias-Silva
MFMelissa Regina Fessel
Melissa Regina Fessel
MAMaria Claudina de Andrade
Maria Claudina de Andrade
LCLuciana Simão Carmo
Luciana Simão Carmo
MLMarcel Liberman
Marcel Liberman
This study investigated the mechanistic intersection between aging, diabetes mellitus (DM), and prelamin A accumulation in vascular calcification (VC) progression in patients with peripheral arterial disease (PAD) undergoing lower limb amputation. Arterial segments were collected from amputated PAD patients with (PAD + DM, n = 10) and without DM (PAD, n = 8), as well as from non-vascular amputated patients (CTRL, n = 3). Additional in vivo and in vitro experiments were conducted to investigate early-stages of VC and the impact of insulin resistance on prelamin A accumulation and ZMPSTE24 expression. PAD and PAD + DM patients exhibited greater VC than CTRL patients. Prelamin A accumulation was higher in PAD (6.3 ± 5.0 %) and PAD + DM (10.9 ± 6.4 %) than in CTRL (1.2 ± 1.3 %), while ZMPSTE24 expression was lower in PAD (5.2 ± 2.6 %) and PAD + DM (3.1 ± 3.2 %) than in CTRL (20.0 ± 3.8 %), indicating impaired prelamin A processing. Investigation in a murine VC model, aortae from leptin-deficient ob/ob mice showed increased prelamin A accumulation, independently of calcifying stimulation. Increased prelamin A expression was also observed insulin-resistant ob/ob VSMCs, independently of calcifying stimulation. These findings suggest that aging-related mechanisms, such as prelamin A accumulation, may synergistically contribute to VC progression, particularly in diabetic PAD patients. Targeting prelamin A processing may unveil a potential therapeutic approach to mitigate VC and reduce amputation risk in diabetic PAD patients.